Badoux, X. C., Keating, M. J., Wang, X., O'Brien, S. M., Ferrajoli, A., Faderl, S., . . . Wierda, W. G. (2011). Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL. American Society of Hematology.
Stile di citazione ChicagoBadoux, Xavier C., et al. Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy Is Highly Effective Treatment for Relapsed Patients With CLL. American Society of Hematology, 2011.
Citazione MLABadoux, Xavier C., et al. Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy Is Highly Effective Treatment for Relapsed Patients With CLL. American Society of Hematology, 2011.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.